Analysis for ORCL

$134.47 +3.92 (+3.00%)

📈 Growth — 4/30
💰 Profitability — 14/20
🏦 Financial Health — 12/20
💵 Valuation — 10/20
⚠️ Risk — 6/10

Overall Score: 44/100

Summary:

📈 Growth & Financial Trajectory

Over eight quarters, revenues declined from about $19.18B to about $13.21B, a drop of roughly 31%. Net income fell from about $4.53B to $2.40B, while diluted EPS advanced to $1.45 in the latest quarter, reflecting earnings quality support despite top-line softness. Operating margins remained in the low- to mid-30% range, with the latest quarter near 32% and earlier quarters generally in the 28-31% band. Operating cash flow was positive in most periods, but the latest quarter posted a notable net cash outflow of about -$7.17B driven by investing/financing activity, highlighting a cash-flow mix shift despite steady earnings.

💰 Margins & Cash Flow

Margins show solid operating leverage within a narrow band, with recent quarters around 32% and prior quarters around the high-20s to low-30s. Net cash from operating activities was robust across several quarters, while investing/financing outflows compressed free cash flow in the latest period.

🛡️ Balance Sheet & Liquidity

Total assets are near $261.76B with liabilities around $218.70B and equity roughly $43.06B in the latest quarter. Current assets vs current liabilities yield a liquidity cushion around 1.1x, indicating reasonable resilience but a leveraged equity base that warrants monitoring.